TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
DSGN

Design Therapeutics Inc

Healthcare · Biotechnology · —

13.20$ +4.9% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DSGN
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
100.0% 99.2% 98.7% 98.2% 98.3% 98.4% 98.9%
85.6% 6.5% 76.4% 7.8% 7.3% 9.0% 7.5%
85.6% 98.8% 98.3% 96.8% 97.3% 97.4% 97.2%
0.0% 0.0% 0.3% 0.5% 0.5% 0.7%
0.3% 0.3% -0.3%
0.2% 0.4% 0.6%
4,146.7% 131.0% 2.2% 4.1% 4.1% 4.0% 6.1%
4,145.6% 6.4% 1.4% 3.2% 3.3% 3.4% 5.8%
772.2% 0.1% 0.2% 0.2% 0.3% 0.4%
2,754.4% 3.8% 0.4% 0.9% 0.7% 0.9% 1.0%
-4,046.7% -31.0% 97.8% 95.9% 95.9% 96.0% 93.9%
-4,047.8% -32.7% -12.2% -32.5% -61.3% -90.1% -131.3%
30,211.1% 74.5% 11.8% 16.3% 19.3% 22.4% 25.3%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?